Although it is crucial to identify tick-borne diseases, including Lyme, early, many tests can be inaccurate or difficult to interpret. Chromacode Inc., of Carlsbad, Calif., is looking to help change that. The company reported the commercial launch of its first multiplex test using its High Definition Polymerase Chain Reaction (HDPCR) technology. Chromacode said the HDPCR Tick-Borne Pathogen (TBP) panel is the only multiplex PCR test that detects nine of the most common tick-borne pathogens in a single test.